Health
Oura integrates Menopause Impact Scale with ten women's health platforms
The wearable company is expanding access to its self-reported symptom assessment through third-party telehealth, clinic, and diagnostic services.
The short version
- Oura announced partnerships with 10 women's health and diagnostic companies to integrate its Menopause Impact Scale assessment into third-party clinical and tracking workflows.
- The tool evaluates 22 symptoms across seven domains to measure how menopause affects daily quality of life.
- Five integrations launched immediately, with the remaining five scheduled to roll out later in the year.
Key facts
- Oura's Menopause Impact Scale (MIS) is expanding into partnerships with 10 women's health companies, including Alloy Health, Maven, Wisp, and Oova.[CNET]
- The MIS is a self-reported questionnaire assessing 22 symptoms across seven quality-of-life domains over a two-week period, generating a score between 0 and 28.[CNET]
- According to Oura, over 600,000 members have completed the assessment, with approximately 35% repeating it at least once.[CNET]
- Integrations with Alloy Health, Oova, Xella, Pomelo, and Wisp are active, while partnerships with Maven, Mira, Hertility, Gennev, and Tia are slated for later this year.[CNET]
- Access to the scale requires purchasing an Oura Ring, which starts at $399, plus an ongoing $6 monthly subscription.[CNET]
What remains uncertain
- Specific launch dates for integrations with Maven, Mira, Hertility, Gennev, and Tia remain unannounced beyond later this year.[CNET]